tirzepatide active ingredient | C225H348N48O68 | CID 156588324 Mounjaro's Active Ingredient: What Is
Description
Very few side effects, if any

No insurance headaches

That might sound modest until you consider that these patients had already plateaued on their previous medication

Plateaued on maximum-dose semaglutide
Having separate products for separate delivery methods, injectable for maximum efficacy and oral for maximum convenience, creates a larger combined market than a single product trying to do both

In a study with eight poorly controlled T2DM patients who received a liquid meal via a nasogastric tube and exogenous infusion of GLP-1 to achieve plasma levels of about 70 pM, gastric volume remained constant over 2 hours, and plasma glucose returned to normal fasting values within 3 4 hours (152)